Lv1
30 积分 2026-05-23 加入
Combining antibody-drug conjugates with immunotherapy in solid tumors: current landscape and future perspectives
2小时前
待确认
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
8小时前
已完结
皖公网安备34019202002308
